EOEun-Taex Oh

Eun-Taex Oh

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Eun-Taex Oh has a total of 34 co-authors. Here are the top co-authors by number of shared publications:

  • Heon Joo Park

    Department of Microbiology

    6 shared publications
  • Keun-Hyeung Lee

    Education and Research Center for Smart Energy Materials and Process, Department of Chemistry and Chemical Engineering, Inha University, Incheon 402-751, South Korea

    6 shared publications
  • Ha Gyeong Kim

    Program in Biomedical Science & Engineering, Inha University, Incheon 22212, Republic of Korea

    5 shared publications
  • Heon Joo Park

    Program in Biomedical Sciences & Engineering

    5 shared publications
  • Sumita Subedi

    Education and Research Center for Smart Energy Materials and Process, Department of Chemistry and Chemical Engineering, Inha University, Incheon 402-751, South Korea

    4 shared publications
  • Chulhee Kim

    Department of Polymer Science and Engineering, Program in Environmental and Polymer Engineering, Inha University, Incheon 22212, Korea

    2 shared publications

Latest Publications

  • Open Access

    Ultrafast fluorescent detection of mercury( ii ) ions in aqueous and biological systems using a boronic acid-based reaction probe

    by Kishor Khadka, Sumita Subedi, Eun-Taex Oh, Keun-Hyeung Lee

    A phenylboronic acid-based fluorescent probe enables rapid fluorescence detection of Hg 2+ by an irreversible reaction between Hg 2+ and a phenylboronic acid moiety via a unique intermolecular self-activation mechanism.


  • Open Access

    Acetylcholine enhances HIF-1α signaling in pancreatic cancer cells under hypoxia through the nAChR-α7/PDPK1/YAP pathway

    by Yunmi Cho, Ha Gyeong Kim, Ju-Hee Kang, Eun-Taex Oh, Heon Joo Park

    Recent studies have extensively addressed the potential role of the autonomic nervous system, which extensively innervates the pancreas, in the development of pancreatic ductal adenocarcinoma (PDAC). Targeting hypoxia-inducible factor-1 (HIF-1) for cancer management has attracted significant research interest, in view of the finding that HIF-1 regulates the expression of various genes involved in tumor angiogenesis, metastasis, proliferation, chemoresistance, and radioresistance. In this study, we investigated the molecular mechanisms by which the neurotransmitter acetylcholine enhances the expression of HIF-1α in pancreatic cancer cells in hypoxia. Under hypoxic conditions, acetylcholine induced a concentration-dependent increase in nAChR-α7-mediated HIF-1α expression in pancreatic cancer cells in vitro, leading to enhanced expression of HIF-1α target genes. It also increased HIF-1α protein stability in pancreatic cancer cells under hypoxic conditions. The acetylcholine-induced elevation of HIF-1α expression was blocked by siRNA-mediated knockdown of PDPK1/YAP signaling, indicating a role for this pathway in mediating these effects. A bioinformatics analysis of publicly available clinical datasets revealed that overall survival was significantly poorer in patients with CHRNA7 copy number amplification, whereas those with high CHRNA7 mRNA expression showed a non-significant trend toward reduced survival, suggesting that copy number alterations have stronger clinical relevance than mRNA levels. Functionally, α-bungarotoxin, a nAChR-α7-specific inhibitor, markedly blunted the acetylcholine-induced increase in the viability of pancreatic cancer organoids under hypoxic conditions. In a mouse xenograft model, acetylcholine administration accelerated tumor growth in animals bearing control pancreatic cancer cells but not in those implanted with nAChR-α7-knockdown cells. Collectively, our findings reveal a novel mechanism of acetylcholine-induced enhancement of HIF-1α expression involving PDPK1/YAP signaling and highlight the utility of HIF-1α as a therapeutic target in acetylcholine-potentiated pancreatic cancer.


  • Open Access

    Nano-Engineered Delivery of the Pro-Apoptotic KLA Peptide: Strategies, Synergies, and Future Directions

    by Yunmi Cho, Ha Gyeong Kim, Eun-Taex Oh

    Antimicrobial peptides have been increasingly recognized as potential anticancer agents, with the KLA peptide (KLAKLAK2) being one of the most well-known and successful examples. The research interest in the KLA peptide is attributed to its ability to induce apoptosis in cancer cells by disrupting the mitochondrial membrane. However, the KLA peptide exhibits poor cellular uptake and it lacks targeting specificity, limiting its clinical potential in cancer therapy. In this review, recent advances in nano-engineered delivery platforms for overcoming the limitations of KLA peptides and enhancing their anticancer efficacy are discussed. Specifically, various nanocarrier systems that enable targeted delivery, controlled release and/or improved bioavailability, including pH-responsive nanosystems, photo-chemo combination liposomes, self-assembled peptide-based nanostructures, nanogel-based delivery systems, homing domain-conjugated KLA structures, inorganic-based nanoparticles, and biomimetic nanocarriers, are highlighted. Additionally, synergistic strategies for combining KLA with chemotherapeutic agents or immunotherapeutic agents to overcome resistance mechanisms in cancer cells are examined. Finally, key challenges for the clinical application of these nanotechnologies are summarized and future directions are proposed.


  • Real-Time Detection of Methylmercury and Hg(II) Using a Reversible Ratiometric Fluorescent Probe in Cellular and Aqueous Environments

    by Hyojin Park, Eun-Taex Oh, Jieun Park, Sumita Subedi, Heon Joo Park, Keun-Hyeung Lee

    Methylmercury (CH3Hg(I)), produced by the action of aquatic bacteria on inorganic mercury, is the most hazardous among the mercury species. To date, no ratiometric fluorescent probes have been reported for the detection of both CH3Hg(I) and Hg(II) in aquatic environments and in live cells. Herein, we designed a novel fluorescent probe incorporating a peptide containing a histidine residue with self-assembly properties specific to both mercury species and a fluorophore that exhibits red-shifted emissions upon aggregation. The probe effectively detected Hg(II) and CH3Hg(I) in aqueous solutions (1% DMSO) through ratiometric fluorescence sensing with visible-light excitation (445 nm). The probe exhibited high selectivity for Hg(II) and CH3Hg(I) among 19 metal ions, rapid response times (3Hg(I)), low detection limits (12.5 nM for Hg(II) and 248.6 nM for CH3Hg(I)), reversible sensing, and a broad operational pH range. As a result, the probe was successfully employed for rapid and real-time sensing of CH3Hg(I) and Hg(II) in both aquatic environments and live cells through distinct ratiometric fluorescent changes. A comprehensive binding mode study using dynamic light scattering, IR and CD spectroscopy, and NMR spectroscopy revealed that the chelation of mercury species by the peptide with the metal-binding site and the fluorophore triggers the self-assembly of the complex, enabling fast and sensitive ratiometric detection of mercury species. The combination of a self-assembling peptide with a metal-binding site and a responsive fluorophore provides a valuable fluorescent sensing platform for the detection and quantification of specific analytes, particularly in complex matrices.


  • Activatable anticancer peptides with mutually suppressed bioactivity and their induced cytotoxicity by matrix metalloproteinase-2

    by Jeonghun Lee, Ha Gyeong Kim, Eun-Taex Oh

    Using activatable cell penetrating peptides (CPPs) are one of the most important strategies to overcome the low selectivity of CPPs by controlling the activity of positively charged CPPs through conjugation with a negatively charged sequence via an enzyme-mediated cleavable linker. In this study, anionic antimicrobial peptides are utilized as the negatively charged component of these activatable CPPs to gain an additional bioactive function such as selective anticancer therapy after activation by enzymatic cleavage. Without an enzyme, the bioactivities of both anionic and cationic components are mutually suppressed by electrostatic interaction within the intact peptide structure. After enzymatic cleavage, the electrostatic interactions between the negative and positive peptide fragments are disrupted, restoring the individual peptide bioactivities and leading to synergistic anticancer therapeutic efficacy.


  • Open Access

    Identification of miR-6794-3p as a suppressor in pancreatic cancer metastasis

    by Ha Gyeong Kim, Yunmi Cho, Jae-Seon Lee, Eun-Taex Oh, Heon Joo Park

    Metastasis is a major cause of treatment failure in patients with pancreatic cancer, highlighting the urgent need for effective therapeutic strategies. Here, we focused on identifying novel miRNAs with key roles in metastasis of pancreatic cancer. Microarray analysis of miRNA expression in metastatic and non-metastatic pancreatic cancer samples revealed significantly lower expression of miR-6794-3p in the metastatic tumor group. Gain- and loss-of-function approaches using the pancreatic cancer cell lines MIA-PaCa-2 and HPAF-II expressing low and high levels of miR-6794-3p, respectively, indicated a role of miR-6794-3p in suppression of cell invasion, migration, and EMT signaling. Importantly, our results showed that miR-6794-3p exerts its effects by inhibiting expression of the chromatin remodeling factor, RBBP4. The resulting suppression of RBBP4 induced an increase in the levels of GRHL2 involved in regulating invasion, migration, and EMT signaling in metastatic pancreatic cancer cells. Consistent with these findings, low miR-6794-3p expression levels correlate with poor pancreatic cancer patient survival. Additional preclinical experiments on nude mice clearly demonstrated inhibitory effects of miR-6794-3p on pancreatic cancer cell metastasis. The collective results highlight the functional significance of miR-6794-3p as a suppressor of metastasis and support its predictive utility as a prognostic biomarker and therapeutic target in pancreatic cancer.


  • Ratiometric Fluorescence Sensing System for Lead Ions Based on Self-Assembly of Bioprobes Triggered by Specific Pb2+–Peptide Interactions

    by Pramod Kumar Mehta, JaeYoon Lee, Eun-Taex Oh, Heon Joo Park, Keun-Hyeung Lee

    Lead is one of the most toxic substances. However, there are few ratiometric fluorescent probes for sensing Pb2+ in aqueous solution as well as living cells because specific ligands for Pb2+ ions have not been well characterized. Considering the interactions between Pb2+ and peptides, we developed ratiometric fluorescent probes for Pb2+ based on the peptide receptor in two steps. First, we synthesized fluorescent probes (1-3) based on the tetrapeptide receptor (ECEE-NH2) containing hard and soft ligands by conjugation with diverse fluorophores that showed excimer emission when they aggregated. After investigation of fluorescent responses to metal ions, benzothiazolyl-cyanovinylene was evaluated as an appropriate fluorophore for ratiometric detection of Pb2+. Next, we modified the peptide receptor to decrease the number of hard ligands and/or to replace Cys with disulfide bond and methylated Cys for improving selectivity and cell permeability. From this process, we developed two fluorescent probes (3 and 8) among the probes (1-8) that exhibited remarkable ratiometric sensing properties for Pb2+ including high water solubility (≤2% DMF), visible light excitation, high sensitivity, selectivity for Pb2+, low detection limits (2+-peptide interactions of the probes caused nanosized aggregates in which the fluorophores of the probes came close each other, exhibiting excimer emission. In particular, 8 based on tetrapeptide bearing a disulfide bond and two carboxyl groups with a good permeability successfully quantified intracellular uptake of Pb2+ in live cells through ratiometric fluorescent signals. The ratiometric sensing system based on specific metal-peptide interactions and excimer emission process could provide a valuable tool to quantify Pb2+ in live cells and pure aqueous solutions.


  • Open Access

    Tuning of Peptide Cytotoxicity with Cell Penetrating Motif Activatable by Matrix Metalloproteinase-2

    by Jeonghun Lee, Eun-Taex Oh, Hae-June Lee, Eunkyoung Lee, Ha Gyeong Kim, Heon Joo Park, Chulhee Kim

    Although diverse cell penetrating motifs not only from naturally occurring proteins but also from synthetic peptides have been discovered and developed, the selectivity of cargo delivery connected to these motifs into the desired target cells is generally low. Here, we demonstrate the selective cytotoxicity tuning of an anticancer KLA peptide with a cell penetrating motif activatable by matrix metalloproteinase-2 (MMP2). The anionic masking sequence introduced at the end of the KLA peptide through an MMP2-cleavable linker is selectively cleaved by MMP2 and the cationic cell penetrating motif is activated. Upon treatment of the peptide to H1299 cells (high MMP2 level), it is selectively internalized into the cells by MMP2, which consequently induces membrane disruption and cell death. In contrast, the peptide shows negligible cytotoxicity toward A549 cancer cells with low MMP2 levels. Furthermore, the selective therapeutic efficacy of the peptide induced by MMP2 is also corroborated using in vivo study.